Harrow, Inc.

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Harrow, Inc. and other ETFs, options, and stocks.

About HROW

Harrow, Inc. engages in the development, production, and sale of innovative medications. It operates through the following segments: Pharmaceutical Compounding and Pharmaceutical Drug Development.

CEO

Mark L. Baum

CEOMark L. Baum

Employees

382

Employees382

Headquarters

Nashville, Tennessee

HeadquartersNashville, Tennessee

Founded

2006

Founded2006

Employees

382

Employees382

HROW Key Statistics

Market cap

1.09B

Market cap1.09B

Price-Earnings ratio

-48.76

Price-Earnings ratio-48.76

Dividend yield

—

Dividend yield—

Average volume

482.21K

Average volume482.21K

High today

$29.67

High today$29.67

Low today

$28.96

Low today$28.96

Open price

$29.01

Open price$29.01

Volume

331.39K

Volume331.39K

52 Week high

$59.23

52 Week high$59.23

52 Week low

$16.87

52 Week low$16.87

People also own

Based on the portfolios of people who own HROW. This list is generated using Robinhood data, and it’s not a recommendation.